Evidence Hub

Elevated fecal calprotectin values appear more common following esophagogastric than colon surgery

Schnedl WJ, Michaelis S, Schrittwieser R, Enko D, Holasek SJ

Journal of surgical case reports, 2026

81 participants

Abstract

Fecal calprotectin (FCAL) is commonly used to exclude inflammatory bowel disease in patients with symptoms of the irritable bowel syndrome spectrum. This retrospective case-control study evaluated FCAL levels in 81 postoperative patients to assess the impact of different gastrointestinal surgeries. Thirty-one patients had undergone esophago-gastric surgery (fundoplication or Roux-en-Y gastric bypass), and 50 had undergone colon surgery with hemicolectomy. Elevated FCAL levels (>50 μg/g) were observed in 56.7% of patients after esophago-gastric surgery compared with 24% of patients after hemicolectomy. Median FCAL levels were 96 μg/g and 99 μg/g, respectively. Statistically significant differences in FCAL levels were found between patients who underwent left-sided hemicolectomy and those who underwent Roux-en-Y bypass (P P = .042). Overall, elevated FCAL levels were more than twice as common following esophago-gastric surgery, suggesting surgery-specific patterns of postoperative intestinal inflammation.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 81 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free